ABSTRACT. Total IgG concentrations, IgG antibody concentrations to pooled Escherichia coli antigens, and IgG anti-E. coli antibody avidity were measured in cord and maternal serum samples collected from 52 mother-infant pairs after premature delivery (mean gestational age 28 wk, range 23-33 wk). The mean IgG anti-E. coli antibody concentration in cord serum (1.86 relative units/mL) was markedly lower than in maternal serum . These findings suggest that there is selective transplacental transport of high avidity antibody with enhanced opsonic activity for these antigens early in the 3rd trimester of pregnancy. (Pediatr Res 27: 365-371, 1990) 
= 0.70; p < 0.001), but cord IgG antibody avidity did not correlate with gestational age (r = -0.07; p = 0.61), nor with cord IgG anti-E. coli antibody concentrations (r = 0.10; p = 0.50). Heat stable serum opsonic activity for the pooled E. coli antigens per unit of IgG antibody, measured by augmentation of normal neutrophil iodination responses, was 2-fold greater in cord serum than maternal serum for the 20 serum pairs tested. Heat stable opsonic activity per unit of IgG antibody correlated closely with IgG antibody avidity in cord and maternal sera (r = 0.96 and 0.94, respectively). These findings suggest that there is selective transplacental transport of high avidity antibody with enhanced opsonic activity for these antigens early in the 3rd trimester of pregnancy. (Pediatr Res 27: 365-371, 1990) Abbreviations EIA, enzyme immunoassay NICU, neonatal intensive care unit PBS-T, PBS-Tween PBS-T/SMP, 2.5% skim milk powder in PBS-T NIMM, neutrophil iodination micro-method Transplacental transfer of maternal IgG antibody provides passively acquired systemic immunity in the neonatal period and early infancy (I), with the greater proportion of placental IgG transport occurring during the last trimester of pregnancy (2) (3) (4) (5) (6) . Low concentrations of transplacentally acquired specific antibody in very premature infants, in conjunction with other microbial and host factors, may contribute to the observed susceptibility of these infants to infection (1, 3, 7-1 1).
The relationship of neonatal serum IgG concentrations and gestational age has been described by several investigators (1, 2, 4, 9, 12) , as has the relationship of IgG subclass transplacental transfer and gestational age (9, 1 1, 13). However, there are relatively few studies of specific antibody transfer in prematurity (2, 7, 8, 14, 15) , and little is known of the functional capacity of maternally derived antibody in the neonate. Sato et al. (14) showed that cord sera from term infants had higher concentrations of neutralizing antibodies to measles, mumps, and rubella than did paired maternal sera. The mean ratio of cord blood to maternal neutralizing antibody was greater for measles than for mumps or rubella, suggesting differential transport of functional antibody. Chudwin et al. (8) found low concentrations of antibody against type 7F pneumococcal polysaccharide and low opsonic activity to this antigen in cord sera from preterm and term neonates in comparison with paired maternal sera, although the mean cord serum total IgG concentrations were greater than maternal IgG concentrations.
In a recent study (16) , IgG-dependent opsonic activity for coagulase negative staphylococci was found to be significantly lower in serum collected from premature neonates during the first 2 wk of life than in paired maternal serum samples. These findings were similar to those reported previously by Fleer et al. (15) , and the authors suggested either that there may be preferential transport of some IgG antibodies across the placenta, or that the function of some IgG antibodies may be impaired by placental transport.
Antibody avidity is an important determinant of antibody efficacy (1 7-19) . To further investigate the functional characteristics of transplacentally acquired IgG antibody in premature neonates, we measured total IgG concentrations, concentrations of IgG antibody to a pooled Escherichia coli antigen preparation, and the avidity of IgG anti-E.coli antibody in paired cord and maternal serum samples from 52 neonates delivered between 23 and 33 wk gestation (mean 28 wk). The opsonic activity of anti-E.coli antibody was determined in 20 paired cord and maternal sera and the relationship of opsonic activity and antibody avidity was assessed.
were enrolled in the study. Informed written parental consent was obtained in accordance with the guidelines of The Declaration of Helsinki.
All infants enrolled were premature neonates; the mean gestational age was 28 wk (range 23-33 wk; 48 were of 30 wk gestation or less). Gestational age was assessed by serial ultrasonography and by examination of the newborns. None of the infants had any clinical evidence of intrauterine infection.
Venous blood was collected from all 52 mothers within 48 h of delivery. Cord blood from their respective infants was collected by careful venepuncture of the umbilical vein immediately after delivery of the placenta. Samples were refrigerated at +4"C, and sera were separated with 24 h of collection. The sera were frozen immediately after separation and were stored at -70°C in polypropylene containers until assayed.
Quantitation of total serum IgG, IgA, and IgM concentrations.
EIA for the measurement of total IgG, IgA, and IgM concentrations in maternal and cord sera were performed as described previously (20 Ninety-six-well microtiter plates (NUNC, Kamstrup, Denmark) were incubated with 100 uL of a 1/800 dilution of the stock E.coli antigen preparation in 0.05 M bicarbonate buffer (pH 9.5) in each test well for 2 h at 37°C and then overnight at +4"C. After washing, 50 pL/well of serum diluted in PBS-T/ SMP (pH 7.2) was added and incubated for 2 h at 37°C. The addition of SMP was used to improve protein binding (26) . After washing, 50 pL of a 1/1000 dilution of peroxidase conjugated, affinity isolated goat antihuman IgG or IgA or IgM (Tago, Burlingame, CA) in PBS-T/SMP was added and incubated for 2 h at 37°C. The plates were then washed and 50 pL of orthophenylene diamine substrate was added for 15 min. The reaction was stopped by adding 25 pL of 8 N H2S04 to each well. Absorbance values were read at 492 nm using a Titertek Multiscan (Flow Laboratories, McLean, VA).
All samples were tested in duplicate and at four dilutions ranging from 1/10 to 111250 for cord sera and from 1/50 to 116250 for maternal sera, respectively. Mother-infant pairs of sera were tested in adjacent rows on the same microtiter plates. The pooled human reference serum (21) Avidity of IgG antibody for pooled E.coli antigens. The avidity of IgG antibody for the pooled E.coli antigens was estimated by using a modified EIA incorporating thiocyanate elution as described previously (1 9, 27) . Preliminary experiments were performed to ensure that no elution of solid phase bound E.coli antigen occurred at any of the molarities of thiocyanate used in subsequent assays and the assays were performed in antigen excess for all isotypes. Under these conditions, the avidity of IgG antibody is unchanged when whole serum is compared with serum depleted of IgA and IgM by immunoadsorption (28) .
Ninety-six-well microtiter plates were coated with the same E.coli antigen as described above. After four washes with PBS-T, 50 pL of serum sample in PBS-T/SMP was incubated in series of duplicate wells for 2 h at 37°C. For each sample a dilution was used at which, in preliminary experiments, antigen excess had been demonstrated for each Ig isotype and at which further dilution of the sample did not affect the estimation of the avidity index.
After washing with PBS-T, bound antibody was eluted by adding 100 pL ammonium thiocyanate (NH4SCN) in 0.1 M phosphate buffer (pH 6.0) to the appropriate wells in duplicate, in concentrations ranging from 1.0 to 4.0 M. On each test plate, four replicate wells for each sample were incubated with phosphate buffer alone. Results for these wells represented 100% antibody binding. The plates were incubated for exactly 30 min at room temperature before washing three times with PBS-T and proceeding with the assay for residual IgG anti-E.coli antibody as described above. Sample-free background values were subtracted from each absorbance reading. The relative avidity index for each sample was defined as the molarity of thiocyanate required to reduce the absorbance (OD value) of the E.coli EIA by 50% and was derived from the elution curves as described previously (19, 27, 29) . The data for each sample were fitted to a graph of log,, (% of initial absorbance) versus molarity of NH4SCN by third degree polynomial regression analysis, using a graph generation program (Grafit/1000, Corporate Computer Systems, NJ) on a Hewlett-Packard 1000 computer (HewlettPackard Co., Palo Alto, CA) (27) .
Serum opsonic activity for pooled E.coli antigens. NIMM was used to measure opsonic activity by determining neutrophil incorporation of radiolabelled iodide in the presence of test serum samples in comparison with a pooled normal adult human serum standard as described previously (30, 31) . Assays for opsonic activity were performed on the 20 cord and maternal paired serum samples for which sufficient sample was available.
In brief, polymorphonuclear leucocytes were isolated from peripheral blood from a healthy adult donor on a Ficol-Isopaque density gradient followed by dextran sedimentation (T500, Pharmacia Fine Chemicals, Piscataway, NJ, 6% in Dulbecco's PBS). Neutrophils recovered were washed and resuspended in iodination buffer [I37 mM NaCl, 2.6 mM KC1, 8.1 mM Na2HP04, 1.5 mM KH2P04, 1.0 mM MgC12.6H20, and 1.0 mM CaC12 (fused)] (3 1). Heat-killed E.coli antigen was prepared by heating the same pool of E.coli strains described above for 30 min at 8O0C, washing the organisms three times in PBS and resuspending in neutrophil iodination buffer to an OD of 1.6 at 540 nm (3 1). The protein and nucleic acid concentration of the antigen preparation were 0.39 and 0.042 mg/mL, respectively. The antigen preparation contained 4.5* lo5 endotoxin units/mL.
Assays were performed in duplicate in microtitre plates (Cooke PLACENTAL TRANSFER OF E. COLZ ANTIBODY 367
Engineering, Edwardstown, South Australia), the reaction mixture consisting of 50 pL of neutrophil suspension (1 x 106/well), 50 pL iodination buffer containing 2.2 mM D-glucose, 50 pL of 80 pm Nal in iodination buffer to which was added Na1251 to an activity of 4 pCi/mL, 50 pL of pooled heat killed E.coli antigen, and 25 pL of a 114 dilution of serum sample (final serum concentration 2.8%). Paired cord and maternal sera were tested on the same plate. The plates were incubated for 60 min at 37"C, and the cells harvested onto glass fiber filters using a Titertek Cell Harvester (Skatron, Norway) which were then washed and air dried for 10 s. The glass fiber discs were placed in polystyrene tubes and the J251 activitylmin recorded on a gamma counter (Minaxi, Auto gamma 5000 series, Packard Instrument Co., Inc., Downers Grove, IL). Serum-free controls were included in each assay to determine nonspecific incorporation of '251, the mean value for which was subtracted from test values. Mean values were less than the 1 % of results for serum containing wells. Pooled human adult serum from eight healthy donors that had been stored in glass at -70°C after collection was used in each assay as a standard. Opsonic activity of test samples was determined using untreated serum (total opsonic activity) and serum heated to 56°C for 30 min (heat stable opsonic activity). Heat labile opsonic activity was derived from the difference between total and heat stable opsonic' activity. Results for test samples were calculated as nmoles of' iodine fixed per lo6 cells and were expressed as a percentage of the mean for the results for the untreated pooled adult serum standard to correct for differing polymorphonuclear leucocyte donor preparations as described previously (30) . The mean results for the standard serum for the two polymorphonuclear leucocyte preparations used were 0.507 and 1.43 nmol Iz5I/lO6 cells, respectively.
Specific heat stable opsonic activity and antibody avidity. Heat stable opsonic activity per relative unit of IgG anti-E.coli antibody (specific heat stable opsonic activity) was calculated for all test samples. Correlations were sought between specific heat stable opsonic activity and IgG antibody avidity per relative unit of IgG anti-E.coli antibody (specific IgG antibody avidity).
Quality control. The intra-and interassay coefficients of variation for each of the total Ig, E.coli antibody, and antibody avidity assays were calculated using the replicate values for the reference serum (32) . The results ranged between 0.6 and 10.6%.
Statistics for data analysis. Logarithmic transformations of all data were used to derive mean values and for statistical analyses. Comparative analyses of paired samples were performed using the paired t test. Pearson correlation analyses were used to determine correlations for paired cord and maternal serum samples. Partial correlation coefficients were calculated to correct for the effect of gestational age, maternal IgG concentrations, or maternal IgG anti-E.coli antibody concentrations as appropriate when comparing maternal and cord values.
RESULTS
Total IgG, IgA, and IgM concentrations. All sera contained IgG. The mean IgG concentrations for cord and maternal sera are shown in Table 1 . The total IgG concentration was significantly higher for maternal sera than for paired cord sera ( p < 0.0001). Cord serum total IgG concentrations increased proportionately with gestational age (Fig. 1) and were significantly correlated with gestational age at delivery when controlled for maternal IgG concentrations (partial correlation coefficient 0.55; p < 0.001). However, cord serum total IgG concentrations in these neonates correlated only weakly with maternal total IgG concentrations, even when controlled for the effect of gestational age (partial correlation coefficient 0.20; p = 0.08).
The mean cord: maternal ratio for serum total IgG concentrations was 0.72 (Table I ). The cord: maternal ratio for total IgG concentrations increased with increasing gestation. There was a significant correlation between the cord: maternal ratio for IgG concentrations and gestational age (r = 0.48; p < 0.001).
All sera had detectable IgA concentrations, with only very low levels of IgA being present in cord serum samples. The mean concentrations for total IgA in maternal and cord sera were 85.7 and 0.33 IU/mL, respectively (range 27.0-322.0 and 0.04-5.4 IU/mL) (p < 0.0001). The mean concentrations for total IgM in maternal and cord sera were 176 and 10.1 IU/mL, respectively (range 63.0-490.0 and 3.6-68.9 IU/mL) ( p < 0.0001). There was no significant correlation between maternal and cord IgA concentrations (r = 0.02) or IgM concentrations (r = 0.20). There was no correlation between gestational age and total IgA concentrations or total IgM concentrations in cord sera (r = 0.16; p = 0.27 and r = 0.12; p = 0.41, respectively).
Antibody to pooled E.coli antigens. All sera had detectable IgG antibody to the pooled E.coli antigens. The mean IgG anti-E.coli antibody concentrations for cord and maternal sera are shown in Table 1 . As for total IgG, the values for IgG anti-E.coli antibody concentrations were significantly higher for maternal sera than for paired cord serum samples ( p < 0.0001).
The concentrations of IgG antibody to E.coli in cord sera correlated weakly with gestational age (Fig. 2A) Fig. 2B ; r = 0.42; p < 0.00 1).
Only 24 of the 52 cord sera from premature neonates had detectable IgA antibodies to the E.coli antigens. Values were very low, the maximum concentration of IgA anti-E.coli antibody detected being 0.6 relative units/mL.
IgM antibody to E.coli was detected in 48 of the 52 cord sera, the maximum concentration being 1.9 relative units/mL. Cord serum IgA and IgM anti-E.coli antibody concentrations correlated poorly with gestational age at delivery (r = 0.002; p = 0.99 and r = 0.24; p = 0.11, respectively).
IgA and IgM anti-E.coli antibodies were detected in all maternal sera. The mean IgA and IgM antibody concentrations were 9.9 relative units/mL (range 1.7-142.0) and 18.7 relative units/ mL (range 2.2-134.0), respectively. There were no significant correlations between cord and maternal IgA or IgM anti-E.coli antibody concentrations (r 5 0.22).
Comparison of cord:maternal ratios for IgG anti-E.coli antibody concentrations and total IgG concentrations. The mean cord: maternal ratio for IgG anti-E.coli antibody was markedly lower than the mean cord: maternal ratio for total IgG concentrations (0.34 versus 0.72; p < 0.001).
Avidity of IgG antibody for pooled E.coli antigens. The mean avidity index for IgG anti-E.coli antibody in cord sera was 2.45 M. This value was significantly greater than the mean avidity index of 1.99 M for paired maternal sera ( p < 0.000 1) ( Table 1 ).
The mean cord:maternal ratio for IgG antibody avidity was 1.23. There was a significant correlation between the avidity indices of paired cord and maternal serum samples (r = 0.70; p <0.00 1). However, there was no correlation between the avidity indices in cord sera and gestational age at premature delivery (r = -0.07; p = 0.6 1). There was no correlation between the avidity indices of IgG anti-E.coli antibody and total IgG concentrations or IgG anti-E.coli concentrations in cord or maternal serum samples (all r < 0.13).
Serum opsonic activity for pooled E.coli antigens. The results for total IgG concentrations, IgG anti-E.coli antibody concentrations, and IgG antibody avidity indices for the 20 paired cord and maternal serum samples on whom assays of opsonic activity were performed are shown in Table 2 . The mean gestational age of these 20 neonates was 28.5 wk (range 26-3 1 wk).
The mean total opsonic activity for the pooled E.coli antigens was greater in maternal samples than in paired cord serum samples (cord-maternal ratio 0.44) (Table 3) . However, the difference between cord and maternal samples was less after heating at 56°C for 30 min (cord-maternal ratio 0.84). Heat labile opsonic Gestational age (weeks) Fig. 1 . Total IgG concentrations (IU/mL) in cord sera at different gestational ages. activity was much lower in cord serum than in paired maternal serum (cord-maternal ratio 0.2 1) ( Table 3) .
The mean heat stable opsonic activity as a proportion of total opsonic activity was 0.64 and 0.34 for cord and maternal sera, respectively. Total and heat stable opsonic activity in cord samples correlated significantly with values for maternal samples (r = 0.58, p < 0.01; r = 0.48, p = 0.03, respectively). A significant correlation also was present for heat labile opsonic activity.
Specific heat-stable opsonic activity and antibody avidity. Heatstable opsonic activity for the pooled E.coli antigens per relative unit of IgG E.coli antibody (specific heat stable opsonic activity) was higher in cord sera than in paired maternal samples (cordmaternal ratio 2.03) with a significant correlation between paired cord and maternal values (r = 0.7 1; p < 0.001) ( Table 4 ). Specific IgG antibody avidity was considerably greater in cord serum (cord-maternal ratio 3.42). There was a close correlation between specific heat stable opsonic activity and specific IgG antibody avidity for cord sera (r = 0.96; p < 0.001) and maternal sera (r = 0.94; p < 0.001) (Fig. 3) .
DISCUSSION
Little is known with respect to the functional capacity of transplacentally acquired antibody in preterm neonates. As part of a longitudinal study of specific and functional antibody in very low birthweight infants, Cates et al. (16) examined the opsonic capacity of sera from 39 preterm neonates for a coagulase-negative Staphylococcus. They found the mean level of IgGdependent opsonic activity in the newborn period to be significantly lower than that for paired maternal serum samples. There 
Gestational a g e (weeks)
Gestational age (weeks) Fig. 2 . A, IgG anti-E.coli antibody concentrations (relative U/mL) in cord sera at different gestational ages. B, ratio of cord: maternal IgG anti-E.coli antibody concentrations at different gestational ages.
was no correlation between maternal and newborn opsonic activity for this organism. Fleer et al. (15) described similar findings and suggested that functional antibody transfer across the placenta may differ from quantitative total antibody transfer. It is possible that antibody avidity may be one of the components of antibody function that accounts for these observed differences.
The study reported here was performed to determine the avidity of IgG antibody for pooled E.coli antigens in cord blood from preterm neonates (mean gestational age 28 wk) in compar- ison with the avidity of maternal IgG antibody for the s a m e Fig. 3 . A, specific heat stable opsonic activity (heat stable opsonic antigen. T h e m e a n relative avidity index for the 52 cord sera activity/relative unit of IgG anti-E.co/i antibody) and specific avidity (M tested was 2.45 M; that for paired maternal sera collected within NH4SCNIrelative unit of IgG anti-E.coli antibody) in cord sera. B, 48 h of birth was significantly lower (1.99 M; p < 0.0001). There specific heat stable opsonic activity (heat stable opsonic activity/relative was a significant correlation of the avidity values for IgG antibody unit of IgG anti-E.coli antibody) and specific avidity (M N H~S C N / to t h e E.coli antigens between paired cord a n d maternal sera ( r relative unit of IgG anti-E.coli antibody) in maternal sera. = 0.70; p < 0.001), but there was n o correlation of the avidity of cord IgG anti-E.coli antibody with gestational age. It is known that there is a close correlation between gestational age and cord or neonatal serum IgG concentrations. Others have demonstrated an increase in cord blood IgG concentrations to values often considerably greater than those for paired maternal serum samples with increasing length of gestation (2, 1 I, 12, 33) , suggesting active transplacental IgG transport. It has been shown also that the concentrations of IgG antibody to specific antigens frequently are greater in cord blood samples than in paired maternal sera later in gestation, although the ratio of cord to maternal antibody concentrations may differ for different antigens (7, 13, 14) .
Similar results were shown for the very premature infants enrolled in the study reported here. Cord blood total IgG concentrations correlated with gestational age (partial correlation coefficient, controlled for maternal IgG concentrations, 0.55; p < 0.00 1) but were poorly correlated with maternal IgG concentrations, even when controlled for the effect of varying gestational age by use of partial regression analysis (r = 0.20; p = 0.08). These results suggest that gestational age is a more important determinant of transplacental IgG transport in prematurity than is total maternal IgG concentration.
However, IgG antibody concentrations in cord sera to E.coli antigens correlated weakly with gestational age (partial correlation coefficient, controlled for maternal IgG anti-E.coli antibody concentrations, 0.23; p = 0.06). Thus, it appears that factors other than total IgG transport determine maternal to fetal transfer of IgG anti-E.coli antibody in prematurity. This is supported by the finding that the mean cord:maternal IgG anti-E.coli antibody ratio of 0.34 was significantly lower than the mean cord:maternal total IgG ratio of 0.72. Maternal IgG anti-E.coli antibody concentrations are important with respect to specific antibody transfer to the neonate as shown by the close correlation of cord and maternal IgG E.coli antibody concentrations when controlled for the effect of gestational age (partial correlation coefficient 0.89; p < 0.00 1). When cord IgG anti-E.coli antibody concentrations were expressed as a proportion of maternal IgG anti-E.coli antibody concentrations, a relatively weak but significant correlation with gestational age was seen (r = 0.42; p < 0.001). For maternofetal transfer of IgG anti-E.coli antibody, the maternal IgG anti-E.coli concentration is a more important factor than gestational age in determining fetal IgG anti-E.coli concentrations.
The relatively low cord: maternal ratio of IgG anti-E.coli antibody contrasts markedly with the finding of a significantly higher avidity of IgG anti-E.coli antibody in cord sera in comparison with paired maternal sera in this study. This finding suggests that there is selective transport of high avidity IgG anti-E.coli antibody from maternal serum. Transport of high avidity antibody could be a compensatory mechanism for the lower total concentration of antibody, providing the neonate with antibody of greater functional activity. The antigen preparation used for the assays of antibody avidity consisted of a mixture of surface and internal E.coli antigens, the latter probably being of limited importance in host-recognition and clearance in vivo. To investigate the significance of the findings with respect to antibody avidity further, assays of opsonic activity of paired cord and maternal sera were performed, using heat killed organisms of the same pooled E.coli strains as for the antibody and avidity assays. The neutrophil iodination assay chosen uses neutrophil oxidative metabolic activation as an indirect measure of opsonisation and correlates closely with other measures of opsonisation and microbicidal activity (30, 3 l) . Untreated serum represents the total opsonic capacity of serum (antibody, complement, and other factors) to promote attachment, ingestion, degranulation, and metabolic activation of polymorphonuclear leucocytes in the presence of organisms. Prior heating of the serum to 56°C was used to provide an estimate of the proportion of the total serum opsonic activity related to complement activity.
The results of these assays showed that total opsonic activity in cord serum samples for the pooled E.coli antigens was only 44% of that of paired maternal serum samples, with the majority of the difference between cord and maternal serum samples being due to deficiencies of heat labile factors (largely complement) as expected (3, 34) . However, at the serum concentrations used in the opsonic assays (2.8%), chosen to give optimal enhancement of iodination responses (30, 31, 35) , heat stable opsonic activity in the cord serum samples from these very premature neonates was 84% of that of the maternal samples. Heat stabile opsonic activity accounted for 64% of the total opsonic activity of cord serum, but only one-third of the total activity of maternal serum. When corrected for IgG anti-E.coli antibody concentrations, which were markedly lower in cord sera than in maternal sera, the heat stable opsonic activity per unit of IgG anti-E.coli antibody was 2-fold greater in cord sera than matenal sera. This finding is in contrast to the results of the phagocytosis assays used by Marodi et al. (36) , perhaps because that study used a single E.coli strain (054), which may colonize less frequently and to which serum antibody may not have been present in some of the test samples.
Antibody avidity has been suggested by others to be important for opsonising activity (37, 38) . In our study, IgG anti-E.coli avidity expressed as a measure of antigen-binding capacity of each unit of IgG antibody (specific IgG antibody avidity) correlated closely with heat stable opsonic activity for the pooled E.coli antigens both for cord and maternal sera. Therefore it is likely that the higher avidity of IgG anti-E.coli antibody in cord sera is responsible for the improved heat stable opsonising capacity of cord sera (84% of maternal values), even though IgG anti-E.coli antibody concentrations in cord sera were only 41 % of maternal values for the 20 cord-maternal pairs evaluated. This improvement in heat-stable opsonizing capacity of cord serum may in reality be even greater than that demonstrated in this study, as maternal serum results for heat stable opsonic activity will also in part be due to IgM antibody, which was present in cord serum in much lower concentrations.
Opsonic activity in serum has been shown to correlate with protection in animal models (39, 40) , and IgG antibody may provide greater protection than IgM antibody (35) . Therefore, the selective transplacental transport of IgG antibody of high avidity may have functional importance in improving the protective capacity of the low concentrations of neonatal antibody present. However, the mechanism of selective transport of high avidity IgG antibody is unclear. It seems unlikely that the affinity of antibody for specific antigen will allow preferential Fc-mediated transport per se, but a possible explanation is that antibody of differing IgG subclasses may have different avidity characteristics for the same antigen, as suggested by Persson et al. (38) and Devey et al. (41) . It will be of interest to determine the relative subclass distribution of IgG anti-E.coli antibody in maternal and cord serum in premature neonates of differing gestational ages, and then measure the relative avidity of IgG subclass specific antibody, perhaps by using negative selection procedures to isolate the subclass of interest (38) .
Our findings suggest that selective transplacental transfer of high avidity IgG antibody to E.coli antigens occurs during pregnancy. This selective transfer may afford a mechanism for the provision of greater protection from infection due to E.coli in the neonatal period, and may be of relevance with respect to neonatal protection from infection by other organisms.
